Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
31 results
D1.149 - Murine IgG1 increased y subcutaneous immunotherapy suppressed development of allergic asthma
D1.150 - Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)
D1.152 - Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units
D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites
D1.154 - Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix
D1.155 - Alterations in B cell memory induced by house dust mite allergen immunotherapy
D1.156 - Early Immunologic Parameters Predicting Response to Sublingual Immunotherapy in Allergic Rhinitis Patients
D1.157 - Type II Cytokine-Mediated Regulation of Alarmin Receptors in B Cells: Implications for Eosinophilic Esophagitis
D1.159 - The successful resolve of nasal polyps in patient with dupilumab treatment
D2.82 - Association between additional corticosteroid usage and Uncontrolled Severe Asthma: A Retrospective Study Using the China Regional Database
D2.83 - Correct Inhaler Technique as a Key Element of Asthma Management: Post-Education Evaluation of Patients' Knowledge
D2.84 - Heterogeneity of Elderly Asthma: a nationwide health and nutrition examination survey
D2.85 - Living a Normal Life with Asthma: Development of a Conceptual Model
D2.86 - Characteristics of Severe type 2 Asthma Patients in China: A Retrospective Observational Study
D2.87 - Disease Burden of Severe Asthma Patients Treated with Medium and High Doses of ICS: A Regional Database Analysis from China
D2.89 - Investigation of Asthma Characteristics in Women with Generalized Periodontitis and Polycystic Ovary Syndrome
D2.90 - Decrease in New-Onset Asthma During the COVID-19 Pandemic
D2.91 - Distribution of Patients with Asthma According to the New Immune Response Classification
D2.92 - Comparison of responsiveness to bronchodilators using the 2021 or 2005 ATS/ERS guidelines: bicenter retrospective study
D2.93 - Differential effects of dupilumab in women with severe uncontrolled asthma
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download